Lawrence Barclay
Managing Partner @ Manta Ray Ventures
London, United Kingdom
Lawrence Barclay is a Series B investor at Manta Ray Ventures in London focused on FinTech and Software. Lawrence Barclay is the Managing Partner @ Manta RAy Ventures. Attended University of Oxford.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Lawrence Barclay invests in
Stages Lawrence Barclay invests in
Countries Lawrence Barclay invests in
Investment Focus
Industry
- FinTech 2 (18%)
- Software 2 (18%)
- Biotechnology 2 (18%)
- Financial Services 2 (18%)
- Information Technology 2 (18%)
Stage
- Series B 3 (27%)
- Seed 2 (18%)
- Series A 2 (18%)
- Series C 2 (18%)
- Pre-Seed 1 (9%)
Country
- United States 3 (27%)
- United Kingdom 2 (18%)
- India 1 (9%)
- Germany 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tequipy
|
Tequipy offers a seamless solution for equipping your team with the necessary hardware, eliminating the hassle of shipping, setup, collections, storage, and support. With just a few clicks, you can remotely configure employee computers and apply security policies to protect your company's intellectual property. | $3.5M / Seed / May 25, 2026 | |
Sitehop
|
Sitehop is a technology company that develops cutting-edge cyber-security and networking solutions. Sitehop's custom FPGA solutions are used to optimize and accelerate cloud/telco networks. | $10M / Series A / Oct 09, 2025 | |
Aqtual
|
Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology and biochemistry for chronic disease. | $31M / Series B / Jul 10, 2025 | |
|
Sitehop
|
Sitehop is a technology company that develops cutting-edge cyber-security and networking solutions. Sitehop's custom FPGA solutions are used to optimize and accelerate cloud/telco networks. | $6.3M / Seed / Feb 28, 2024 | |
Ossium Health
|
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.The cells of the immune system are the human body’s natural defenders against disease. At Ossium, they are developing better methods of recovering, preserving, deploying these critical cells to keepdisease at bay. | $52M / Series C / Jul 25, 2023 | |
Cuemath
|
Cuemath is an international online learning platform that offers math and coding programs for K-to-10 students. Cuemath makes every aspect of learning maths engaging and comprehensive by using math worksheets and application-based technology under the supervision of trained and certified teachers. The Cuemath Program has been designed to build astrong math and coding foundation in children by sharpening their knowledge of concepts, aptitude, and reasoning skills. Cuemath was founded in 2013 and is based in Bengaluru, Karnataka, India. | $57M / Venture - Series Unknown / Jun 01, 2022 | |
Acquicent
|
Acquicent was a financial technology company that operated a marketplace for shares of museum-grade, collectible treasure assets. It ceased operations in December 2024. | $760K / Pre-Seed / Mar 15, 2022 | |
|
Ossium Health
|
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.The cells of the immune system are the human body’s natural defenders against disease. At Ossium, they are developing better methods of recovering, preserving, deploying these critical cells to keepdisease at bay. | $63M / Series B / Mar 18, 2021 | |
|
Cuemath
|
Cuemath is an international online learning platform that offers math and coding programs for K-to-10 students. Cuemath makes every aspect of learning maths engaging and comprehensive by using math worksheets and application-based technology under the supervision of trained and certified teachers. The Cuemath Program has been designed to build astrong math and coding foundation in children by sharpening their knowledge of concepts, aptitude, and reasoning skills. Cuemath was founded in 2013 and is based in Bengaluru, Karnataka, India. | $40M / Series C / Dec 08, 2020 | |
Finiata
|
Finiata provides flexible financing to small companies and freelancers through a line of financing and factoring. They believe strongly in the scientific method, listening to customers, solving real problems, and doing the unscalable to find the scalable. | $8.2M / Series A / Nov 11, 2020 | |
| See all 11 investments → | |||
Co-Investors
About Manta Ray Ventures
Manta Ray Ventures is an early-stage venture capital fund backing mission-driven founders that provides flexible and patient capital, leveraging time, resources, and networks resources and networks as far as possible to support its portfolio companies.
Manta Ray Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Leah Volger
Prinicpal
|
|||
|
Christopher Sisserian
Head of Platform
|
|||
|
Lawrence Barclay
Managing Partner
|
|||
Sebastian Kulczyk
Founder
|
|||
1 more contact available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Lawrence Barclay invest in?
Lawrence Barclay invests primarily in FinTech, Software and Biotechnology startups, most often at Series B and Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Lawrence Barclay last invest?
The most recent investment recorded for Lawrence Barclay closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
